Cardiovascular Research Technologies (CRT) 2025

Cardiovascular Research Technologies (CRT) 2025 is organized by Cardiovascular Research Technologies (CRT) Group Foundation and will be held from Mar 08 - 11, 2025 at Washington Hilton Hotel, Washington, Dist of Col, United States of America.

Description:
Cardiovascular Research Technologies (CRT) is a leading educational forum on new cardiovascular technology and procedures for physicians and health-care professionals. CRT provides a forum for exemplary education for interventional cardiologists, general cardiologists, cardiothoracic and vascular surgeons, catheterization laboratory managers, nurses and technologists, scientists and those with an interest in cardiovascular medicine.

The annual CRT Meeting features focused educational and training sessions that discuss new trial data, explore evidence-based research and demonstrate the most up-to-date techniques that can be directly applied to clinical and academic practices. It consists of concurrent meetings in 10 main areas of interest— Atherosclerosis & Lipids, Coronary, Digital Health and AI, Endovascular, Equity, Inclusion & Diversity, Heart Failure, Nurses and Technologists, Technology and Innovation, Valve and Structural, and Women in Cardiology. CRT attendees have the opportunity to share ideas and knowledge, collaborate on interventional cardiology solutions, receive interventional cardiology training, and network with other professionals.

Join interventional and endovascular specialists at CRT 2025 for a comprehensive four-day interventional cardiology conference in Washington, DC.

Learning Objectives:
Upon completion of this activity, participants should be able to:

• Integrate advances in diagnostic evaluation and therapeutics to treat patients with carotid and peripheral arterial disease
• Employ new interventional technologies, medical therapies and procedures into the care of patients with complex coronary and endovascular disease
• Review recent advances in the medical and mechanical management of heart failure patients across the progression of symptoms and stages
• Discuss which stroke patients are candidates for thrombolytic therapy, and identify those who should receive endovascular thrombectomy
• Appraise percutaneous devices from concept through preclinical and clinical investigation. regulatory approval and clinical application for the treatment of structural heart and valve disease
• Interpret advanced techniques and recent data on the use of renal denervation for the treatment of hypertension
• Outline clinical and social determinants that contribute to racial/gender disparities in cardiovascular disease and employ strategies to factor these inequalities into care and clinical trial recruitment